Patty Eisenhaur
Investor Relations Contact at MOMENTA PHARMACEUTICALS, INC.
Profile
Patty Eisenhaur is currently working as an Investor Relations Contact at Momenta Pharmaceuticals, Inc. and as a Senior Strategist at EVC Group, Inc. Previously, she worked as the Head-Investor Relations at Curia Global, Inc. from 2014 to 2018.
Patty Eisenhaur active positions
| Companies | Position | Start |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| EVC Group, Inc. | Corporate Officer/Principal | - |
Former positions of Patty Eisenhaur
| Companies | Position | End |
|---|---|---|
| ALBANY MOLECULAR RESEARCH, INC. | Investor Relations Contact | 2018-05-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Curia Global, Inc.
 Curia Global, Inc. Miscellaneous Commercial ServicesCommercial Services Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Commercial Services |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
| EVC Group, Inc. |
- Stock Market
- Insiders
- Patty Eisenhaur
